HB0043 not checked

Huahai Pharmaceutical (Huaota)

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
None yet
 
Trials
2 active
3 in total
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Hidradenitis Suppurativa, Acne Vulgaris
Main trialPhase 1/2
“The purpose of this study is to assess efficacy safety and tolerability of HB0043 in adult patients with moderate to severe HS.”In the company’s words, NCT06895499 on ClinicalTrials.gov

Other drugs for Hidradenitis Suppurativa

All 29 drugs for Hidradenitis Suppurativa

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials3

TrialPhaseCompletesWhat it tests
Phase 1/2Recruiting 30 Jan 2026 Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.
Phase 1/2Not yet recruiting 27 Oct 2026 A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris.
Phase 1Completed 12 Feb 2026 A Study to Evaluate Single-dose of HB0043 in Healthy Adult Participants
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow HB0043

Following is part of Solo: you see every change to HB0043 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in